Telesis Bio, Inc.
TBIO
$0.02
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.64M | -- | -8.64M | -17.69M | -10.63M |
| Total Depreciation and Amortization | 791.00K | -- | 1.18M | 1.15M | 912.00K |
| Total Amortization of Deferred Charges | 33.00K | -- | 54.00K | 73.00K | 483.00K |
| Total Other Non-Cash Items | 922.00K | -- | 786.00K | 13.05M | 2.08M |
| Change in Net Operating Assets | -2.06M | -- | 3.39M | -3.90M | 1.29M |
| Cash from Operations | -6.96M | -- | -3.24M | -7.31M | -5.87M |
| Capital Expenditure | -55.00K | -- | -502.00K | -252.00K | -74.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.50M | -- | 12.75M | 6.75M | -23.15M |
| Cash from Investing | 4.45M | -- | 12.25M | 6.50M | -23.22M |
| Total Debt Issued | 5.67M | -- | -- | -- | -- |
| Total Debt Repaid | -5.02M | -- | -19.00K | -15.05M | -11.00K |
| Issuance of Common Stock | 0.00 | -- | 4.00K | 31.00K | 25.00K |
| Repurchase of Common Stock | 0.00 | -- | -12.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 1.00M | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -815.00K | -- | -- | -1.00M | -115.00K |
| Cash from Financing | -168.00K | -- | -27.00K | -15.02M | -101.00K |
| Foreign Exchange rate Adjustments | 4.00K | -- | -6.00K | 13.00K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68M | -- | 8.98M | -15.83M | -29.21M |